Ashleigh Moore
About Ashleigh Moore
Ashleigh Moore is the Senior Director of US Hematology Marketing for REBLOZYL at Bristol Myers Squibb, with extensive experience in pricing, market access, and strategic planning in the pharmaceutical industry.
Senior Director at Bristol Myers Squibb
Ashleigh Moore holds the position of Senior Director for US Hematology Marketing at Bristol Myers Squibb, focusing on the marketing strategy for REBLOZYL. Since October 2022, she has led marketing efforts for this treatment, which aids anemia patients with beta thalassemia and myelodysplastic syndromes. Her role emphasizes strategic planning and market penetration for hematology therapies.
Previous Roles at Bristol Myers Squibb
Before her current position, Ashleigh Moore served as Director of US AML Marketing at Bristol Myers Squibb from 2021 to 2022. She also worked as Director of Strategic Initiatives, Enterprise Strategic Planning, from 2020 to 2021. These roles allowed her to contribute significantly to strategic planning and the marketing of acute myeloid leukemia (AML) treatments, enhancing her expertise in hematology-focused pharmaceutical marketing.
Experience in Pricing and Market Access
Ashleigh Moore's professional journey includes significant experience in pricing and market access strategies. She was a Manager at IQVIA, focusing on Pricing and Market Access, US and Global Strategy, in 2018. Prior to that, she worked at IMS Consulting Group as a Consultant and Associate Consultant in Pricing and Market Access, US and Global Strategy, and Strategy & Portfolio Analysis, respectively. This experience provided her with a solid foundation in market access and strategic pricing in the pharmaceutical industry.
Educational Background in Cellular and Molecular Biology
Ashleigh Moore's educational background is rooted in cellular and molecular biology, which underpins her expertise in hematology marketing. She completed her postdoctoral fellowship at the Sackler Institute of Graduate Biomedical Sciences at NYU School of Medicine, focusing on Cell/Cellular and Molecular Biology. She also earned a Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology and a Bachelor of Science (B.S.) in Biology, General, from the University of South Carolina.
Strategic Initiatives and Enterprise Planning
During her tenure at Bristol Myers Squibb, Ashleigh Moore played a crucial role in strategic initiatives and enterprise strategic planning. Working as Director of Strategic Initiatives, Enterprise Strategic Planning from 2020 to 2021, she contributed to the company's long-term growth plans and strategic direction. This role involved high-level planning and implementation of strategic projects that supported the broader corporate objectives.